What The Senate Health Bill Means For The Drug Industry03:42
Download

Play
This article is more than 2 years old.

The pharmaceutical industry has not taken a position on the Senate's health care bill released Thursday. The bill would eliminate a tax on drug companies, but provisions of the bill that are expected to leave millions more uninsured could hurt sales for drug companies.

Here & Now's Jeremy Hobson speaks with Bloomberg's Keri Geiger (@GeigerWire) about the latest, and about a draft order on drug prices from President Trump which eases a number of regulations on the industry.

This segment aired on June 23, 2017.

Related:

Support the news

+Join the discussion
TwitterfacebookEmail

Support the news